Heart failure is one of the most important
causes of death worldwide.
Heart transplant is the last effective alternative when the medical and surgical
treatments have failed in
patients with end stage
heart failure, giving them an 80% one year
survival rate. Unfortunately, during the outcome, the
heart transplant patients can develop
complications such as
graft rejection and
opportunistic infections because of the use of
immunosuppressive therapy. In the present article we
report the experience with 33
heart transplant patients. Our program not only has successfully transplanted
patients with advanced age but, for the first
time in
Latin America we have transplanted
patients assisted with the ambulatory Thoratec TLC II system. Even with limited
resources, we have managed the same
complications than other
heart transplant programs, our 82% one year
survival rate is
similar than
reports in medical
literature.